AJL Ophthalmic (Spain) and CorneaGen (US) are the Prominent Players in the Artificial Cornea and Corneal Implant Market
The global artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026. Market growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth.
However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of this market during the forecast period
To know about the assumptions considered for the study download the pdf brochure
The prominent players in the artificial cornea and corneal implant industry are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US), L V Prasad Eye Institute (LVPEI, India), New Mexico Lions Eye Bank (NMLEB, US), San Antonio Eye Bank (US), Kansas Eye Bank & Cornea Research Center (US), Rocky Mountain Lions Eye Bank (US), Netherlands Institute for Innovative Ocular Surgery (NIIOS, Netherlands), CTS Eye Bank (UK), The East Anglian Eye Bank (UK), Kensington Health (Canada), and Beijing Tongren Eye Bank (China). These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the artificial cornea and corneal implant market.
AJL Ophthalmic (Spain)
AJL offers the artificial corneal implant through the Ophthalmology segment. The company has a strong product portfolio and a wide geographic presence in over 80 countries globally.
CorneaGen (US)
CorneaGen has processed more than 45,000 corneas as per the stp>
Aurolab (India)
andards set by the FDA and the Eye Bank Association of America. The company has a strong portfolio for corneal disease treatment.Aurolab’s products are exported to more than 130 counties across the globe, including India, Latin America, Africa, Southeast Asia, and Central America.
Massachusetts Eye and Ear (US)
Massachusetts Eye and Ear provides primary care and serves as a referral center for inpatient and outpatient surgical and medical care. It also offers several types of corneal services that provide better quality care.
Florida Lions Eye Bank (US)
The Florida Lions Eye Bank has provided tissue to more than 44,000 cornea transplant recipients.
L V Prasad Eye Institute (LVPEI, India)
LVPEI has served over 30.6 million people, over 50% of them entirely free of cost, irrespective of the complexity of care needed. The LVPEI Eye Care network is spread across the Indian states of Telangana, Odisha, Andhra Pradesh, and Karnataka, with nearly 228 centers providing primary to advanced eye care services.
Related Reports:
Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
